dorsaVi Unveils AI Video Platform and Blockchain Partnership Amid Revenue Rise

Financial Performance and Cash Flow

dorsaVi Ltd (ASX: DVL) has reported a steady financial quarter ending December 2024, with sales revenue edging up by 1.9% to $330,000 compared to the previous quarter. Despite a slight dip in cash receipts from customers to $329,000, the company achieved a positive net operating cash inflow of $86,000, bolstered by a $415,000 government grant related to R&D tax incentives. Operating expenses were carefully managed, declining from $756,000 in Q1 to $665,000 in Q2, reflecting a disciplined approach to cost control.

Launch of the Video AI Movement Analysis Platform

A major highlight for dorsaVi this quarter was the commercial release of its advanced AI-powered Video AI platform. This new product leverages video capture technology to provide high-precision movement analysis without the need for physical sensors, significantly reducing setup time by 90%. Early adoption by professional sports teams and US physical therapy clinics signals strong market interest. The platform’s modular design, covering upper limb, lower limb, and running analysis, caters to diverse clinical and sports performance needs, offering clinicians real-time data to enhance patient outcomes and create new revenue streams.

From a business perspective, the Video AI platform promises higher margins exceeding 70%, as it eliminates costs associated with sensors, shipping, and extensive clinician training. Customers can access the platform instantly via a website download, positioning dorsaVi competitively in the growing digital health market.

Blockchain Integration and Strategic Partnership

In a forward-looking move, dorsaVi has embarked on a strategic feasibility study to integrate blockchain technology into its data platform. This initiative aims to address increasing demands for data security and privacy from enterprise clients handling sensitive health and biomechanical information. The company is exploring advanced consensus mechanisms such as Proof-of-Stake and Directed Acyclic Graphs to ensure energy-efficient and scalable solutions tailored to mobile health data.

Complementing this effort, dorsaVi formed a partnership with Secret Network, a leader in privacy-preserving blockchain technologies. The collaboration will test encrypted smart contracts and data tokenization methods, including NFTs, to secure user movement data. Secret Network is providing development resources at no cost for the proof of concept, underscoring the strategic importance of this initiative.

Board Appointment and Capital Raising

The quarter also saw the appointment of Mr Leigh Travers as a Non-Executive Director. Travers brings over a decade of experience in digital assets and fintech, having led Binance Australia and held senior roles at Animoca Brands and DigitalX Limited. His expertise is expected to accelerate dorsaVi’s blockchain and AI ambitions.

Additionally, dorsaVi completed a $1.1 million capital raise through the issuance of 50 million new shares at 1.1 cents each. The funds are earmarked to accelerate US commercialisation of AI-enhanced products and expand AI capabilities, reinforcing the company’s growth trajectory.

Outlook and Market Positioning

With a cash balance of $1.24 million at quarter-end, including the R&D tax rebate, dorsaVi is well-positioned to fund its strategic initiatives. The combination of innovative AI technology, blockchain integration, and strengthened leadership suggests a company evolving to meet the complex demands of healthcare and sports performance markets. However, the success of these new technologies and partnerships will be critical to watch as dorsaVi seeks to convert early interest into sustained revenue growth.